Download PDF
Thromb Haemost 2005; 94(01): 230-231
DOI: 10.1055/s-0037-1614316
Letters to the Editor
Schattauer GmbH

Rebuttal: Meta-analysis of the relationship of factor V Leiden and intrauterine growth restriction – based on solid evidence?

Pelle G. Lindqvist
1   Department of Clinical Medicine, Malmö University Hospital, Lund University, Malmö, Sweden
,
Juan Merlo
1   Department of Clinical Medicine, Malmö University Hospital, Lund University, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Received 21 January 2005

Accepted after revision 04 April 2005

Publication Date:
15 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004; 91: 700-11.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Lindqvist PG, Svensson PJ, Marsál K. et al. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Infante-Rivard C, Rivard GE, Yotov WV. et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002; 347: 19-25.
    CrossrefPubMedGoogle Scholar
  • 4 Lindqvist PG, Svensson PJ, Dahlbäck B. et al. Factor V Q506 Mutation (activated protein C resistance) associated with reduced intrapartum blood loss – a possible evolutionary selection mechanism. Thromb Haemost 1998; 79: 69-73.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Erhardt E, Stankovics J, Molnar D. et al. High prevalence of factor V Leiden mutation in mothers of premature neonates. Biol Neonate 2000; 78: 145-6.
    CrossrefPubMedGoogle Scholar
  • 6 Kupferminc MJ, Eldor A, Steinman N. et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
    CrossrefPubMedGoogle Scholar
  • 7 Martinelli P, Grandone E, Colaizzo D. et al. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001; 86: 428-31.
    PubMedGoogle Scholar
  • 8 Agorastos T, Karavida A, Lambropoulos A. et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med 2002; 12: 267-73.
    CrossrefPubMedGoogle Scholar
  • 9 Kupferminc MJ, Many A, Bar-Am A. et al. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. BJOG 2002; 109: 1373-6.
    CrossrefPubMedGoogle Scholar
  • 10 Verspyck E, Le CD, Goffinet F. et al. Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants. BJOG 2002; 109: 28-33.
    CrossrefPubMedGoogle Scholar
  • 11 Clark P, Sattar N, Walker ID. et al. The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance. Thromb Haemost 2001; 85: 30-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Attia J, Dudding T, Infante-Rivard C. Addendum to: The association between adverse pregnancy outcomes and maternal factor V Leiden genotype. A meta-analysis. Thromb Haemost 2004; 92: 434.
    Article in Thieme ConnectPubMedGoogle Scholar